Annual Short Term Debt
$1.85 M
+$456.60 K+32.70%
31 December 2023
Summary:
SAB Biotherapeutics annual short term debt is currently $1.85 million, with the most recent change of +$456.60 thousand (+32.70%) on 31 December 2023. During the last 3 years, it has risen by +$195.10 thousand (+11.77%). SABS annual short term debt is now -40.24% below its all-time high of $3.10 million, reached on 31 December 2021.SABS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$524.70 K
-$687.00 K-56.70%
30 September 2024
Summary:
SAB Biotherapeutics quarterly short term debt is currently $524.70 thousand, with the most recent change of -$687.00 thousand (-56.70%) on 30 September 2024. Over the past year, it has dropped by -$675.20 thousand (-56.27%). SABS quarterly short term debt is now -83.08% below its all-time high of $3.10 million, reached on 31 December 2021.SABS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.7% | -56.3% |
| 3 y3 years | +11.8% | +100.0% |
| 5 y5 years | - | - |
SABS Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -40.2% | +32.7% | -83.1% | |
| 5 y | 5 years | -40.2% | +32.7% | -83.1% | |
| alltime | all time | -40.2% | +32.7% | -83.1% |
SAB Biotherapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $524.70 K(-56.7%) |
| June 2024 | - | $1.21 M(-19.9%) |
| Mar 2024 | - | $1.51 M(-18.3%) |
| Dec 2023 | $1.85 M(+32.7%) | $1.85 M(+54.4%) |
| Sept 2023 | - | $1.20 M(+52.9%) |
| June 2023 | - | $784.90 K(-28.3%) |
| Mar 2023 | - | $1.10 M(-21.6%) |
| Dec 2022 | $1.40 M | $1.40 M(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $1.38 M(+3.3%) |
| June 2022 | - | $1.33 M(+0.7%) |
| Mar 2022 | - | $1.33 M(-57.2%) |
| Dec 2021 | $3.10 M(+87.0%) | $3.10 M(>+9900.0%) |
| Sept 2021 | - | $0.00(-100.0%) |
| June 2021 | - | $1.16 M(-30.0%) |
| Dec 2020 | $1.66 M(-14.8%) | $1.66 M |
| Dec 2019 | $1.95 M | - |
FAQ
- What is SAB Biotherapeutics annual short term debt?
- What is the all time high annual short term debt for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual short term debt year-on-year change?
- What is SAB Biotherapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly short term debt year-on-year change?
What is SAB Biotherapeutics annual short term debt?
The current annual short term debt of SABS is $1.85 M
What is the all time high annual short term debt for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual short term debt is $3.10 M
What is SAB Biotherapeutics annual short term debt year-on-year change?
Over the past year, SABS annual short term debt has changed by +$456.60 K (+32.70%)
What is SAB Biotherapeutics quarterly short term debt?
The current quarterly short term debt of SABS is $524.70 K
What is the all time high quarterly short term debt for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly short term debt is $3.10 M
What is SAB Biotherapeutics quarterly short term debt year-on-year change?
Over the past year, SABS quarterly short term debt has changed by -$675.20 K (-56.27%)